Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
teresa.grieco@uniroma1.it
Teresa Grieco
Ricercatore
Struttura:
DIPARTIMENTO DI SCIENZE CLINICHE INTERNISTICHE, ANESTESIOLOGICHE E CARDIOVASCOLARI
E-mail:
teresa.grieco@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Successful use of dupilumab for the treatment of atopic dermatitis on the genitals. a neglected anatomical site
CLINICAL AND EXPERIMENTAL DERMATOLOGY
2022
Effects of Vaccination against COVID-19 in Chronic Spontaneous and Inducible Urticaria (CSU/CIU) Patients: A Monocentric Study
JOURNAL OF CLINICAL MEDICINE
2022
It's Never Too Late To Treat Chronic Spontaneous Urticaria With Omalizumab: Real-Life Data From A Multicenter Observational Study Focusing on Elderly Patients
DERMATOLOGIC THERAPY
2021
New onset of alopecia areata in a patient with SARS-CoV-2 infection: Possible pathogenetic correlations?
JOURNAL OF COSMETIC DERMATOLOGY
2021
Atopic dermatitis in adolescents. effectiveness and safety of dupilumab in a 16-week real-life experience during the COVID-19 pandemic in italy
DERMATOLOGIC THERAPY
2021
Effectiveness and safety of long-term dupilumab treatment in elderly patients with atopic dermatitis. a multicenter real-life observational study
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
2021
Effects of dupilumab in type 1 neurofibromatosis coexisting with severe atopic dermatitis
ANAIS BRASILEIROS DE DERMATOLOGIA
2021
Telogen effluvium after SARS-CoV-2 Infection. a series of cases and possible pathogenetic mechanisms
SKIN APPENDAGE DISORDERS
2021
COVID-19. important updates and developments edited by franco rongioletti, MD, and leonard hoenig, MD Impact of COVID-19 on patients with atopic dermatitis
CLINICS IN DERMATOLOGY
2021
Dupilumab in adolescents with moderate to severe atopic dermatitis. a 32-week real-world experience during the COVID-19 pandemic
CLINICAL AND EXPERIMENTAL DERMATOLOGY
2021
Cutaneous adverse reactions after COVID-19 vaccines in a cohort of 2740 italian subjects. an observational study
DERMATOLOGIC THERAPY
2021
Lymphomatoid drug reaction developed after BNT162b2 (Comirnaty) COVID-19 vaccine manifesting as pityriasis lichenoides et varioliformis acuta-like eruption
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
2021
Dupilumab facial redness: histologic characterization on a series of four cases
IMMUNOTHERAPY
2021
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in italy. data from the DA-COVID-19 registry
ALLERGY
2021
COVID-19 infection and BNT162b2 vaccine triggering sarcoid-like lesions in the same patient Response to: Sarcoid-like reaction in a patient recovering from coronavirus disease 19 pneumonia
JAAD CASE REPORTS
2021
IFN-γ/IL-6 and related cytokines in chronic spontaneous urticaria: evaluation of their pathogenetic role and changes during omalizumab therapy
INTERNATIONAL JOURNAL OF DERMATOLOGY
2020
Atopic dermatitis in the elderly Caucasian population: diagnostic clinical criteria and review of the literature
INTERNATIONAL JOURNAL OF DERMATOLOGY
2020
"Toxic erythema" and eosinophilia associated to tocilizumab therapy in a COVID-19 patient
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
2020
Potential clinical and serological predictors of chronic spontaneous urticaria relapse in patients under omalizumab treatment
IMMUNOTHERAPY
2020
Dupilumab therapy of atopic dermatitis of the elderly. A multi-centre, real-life study
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
2020
1
2
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma